Cite Filings / PLX / 0001104659-22-046052

Feed Companies Filings Check

Sign in

PRE 14A

Proxy Statement (Preliminary)

Protalix BioTherapeutics, Inc. Filed 2022-04-14 Acc 0001104659-22-046052

Documents 1

PRE 14A Proxy Statement (Preliminary) , tm2212755d1_pre14a.htm

Around this filing

2023-05-02 PRE 14A Proxy Statement (Preliminary)
2022-04-20 S-3 Registration Statement
2022-04-14 PRE 14A Proxy Statement (Preliminary)
2022-04-13 4 President and CEO bought 68,000 shares at $1.50 ($102,000)
2021-09-17 PRE 14A Proxy Statement (Preliminary)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2212755d1_pre14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…